Vanguard Fiduciary Trust »

Lucid Diagnostics shares owned by Vanguard Fiduciary Trust

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Vanguard Fiduciary Trust from 13F filings

Historical chart of Vanguard Fiduciary Trust investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by Vanguard Fiduciary Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by Vanguard Fiduciary Trust

Quarter filed Position value Share count Share price at filing
2026-03-31 $717k 624k 1.15

More positions owned by Vanguard Fiduciary Trust

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Fiduciary Trust

Top funds holding Lucid Diagnostics

Vanguard Group
BlackRock
Vanguard Capital Management
Masters Capital Mgmt
Standard Life Aberdeen
Two Seas Capital
Geode Capital Management
Russell Investments
State Street Corporation
Wells Fargo & Company
Perkins Capital Management
Sunbelt Securities
Renaissance Technologies
Northern Trust
Vanguard Fiduciary Trust

View all funds holding Lucid Diagnostics